- €650.00m
- €615.82m
- €103.41m
Annual balance sheet for innoscripta SE, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|
| Period Length: | — | — | — |
| Source: | ARS | ARS | ARS |
| Standards: | GAS | GAS | GAS |
| Status: | Final | Final | Final |
| Cash and Equivalents | |||
| Cash and Short Term Investments | 13.7 | 23.9 | 46.7 |
| Net Total Accounts Receivable | |||
| Net Total Receivables | 19.5 | 31.6 | 50.6 |
| Total Inventory | |||
| Total Other Current Assets | |||
| Total Current Assets | 34.6 | 58.2 | 100 |
| Net Property, Plant And Equipment | 0.389 | 0.302 | 0.318 |
| Net Intangible Assets | |||
| Long Term Investments | |||
| Other Long Term Assets | |||
| Total Assets | 35.4 | 58.8 | 101 |
| Accounts Payable | |||
| Accrued Expenses | |||
| Notes Payable / Short Term Debt | |||
| Current Portion of Long Term Debt / Capital Leases | |||
| Total Other Current Liabilities | |||
| Total Current Liabilities | 3 | 5.68 | 9.56 |
| Long Term Debt | |||
| Total Long Term Debt | |||
| Total Debt | |||
| Total Other Liabilities | |||
| Total Liabilities | 17.3 | 23.7 | 47.2 |
| Common Stock | |||
| Retained Earnings (Accumulated Deficit) | |||
| Other Equity | |||
| Total Equity | 18.1 | 35.1 | 53.8 |
| Total Liabilities & Shareholders' Equity | 35.4 | 58.8 | 101 |
| Total Common Shares Outstanding |